{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:04:28Z","timestamp":1773468268184,"version":"3.50.1"},"reference-count":44,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver condition with significant risk of progression to steatohepatitis and cirrhosis. Therapeutic strategies in NAFLD include lifestyle changes mainly related to dietary interventions and use of drugs or nutritional components that could improve plasma lipid profiles and insulin sensitivity and decrease the local inflammatory response. In this study, we tested the effects of monacolin K, an inhibitor of HMCoA reductase. In a prospective, uncontrolled, open study, we treated 24 patients with NAFLD and mild hypercholesterolemia with 10 mg\/day of monacolin K. At baseline and after 26 weeks, we measured in plasma liver tests, lipids, malondialdehyde, and oxidized glutathione, and assessed biochemical steatosis scores, liver elastography, and body composition with bioimpedance analysis. Monacolin K significantly reduced plasma alanine aminotransferase, cholesterol, triglycerides and the homeostatic model assessment (HOMA) index that indicated improved insulin sensitivity. No significant changes were found in body fat mass and visceral fat, nor in liver elastography, while the fatty liver index (FLI) was significantly decreased. Plasma levels of both malondialdehyde and oxidized glutathione were markedly reduced by monacolin K treatment, suggesting a reduction in oxidative stress and lipid peroxidation. In summary, this pilot study suggests possible benefits of monacolin K use in NAFLD patients that could be linked to a reduction in oxidative stress. This hypothesis should be further investigated in future studies.<\/jats:p>","DOI":"10.3390\/nu15081887","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T01:32:03Z","timestamp":1681435923000},"page":"1887","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Andrea","family":"Da Porto","sequence":"first","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Diabetes and Metabolism Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Donnini","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Liver Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Vanin","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Liver Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Romanin","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Liver Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Antonello","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Diabetes and Metabolism Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Toritto","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Liver Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Varisco","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Liver Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Brosolo","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Catena","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-0209","authenticated-orcid":false,"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-5651","authenticated-orcid":false,"given":"Giorgio","family":"Soardo","sequence":"additional","affiliation":[{"name":"Clinica Medica, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Liver Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"},{"name":"Italian Liver Foundation, Area Science Park, Basovizza, 34149 Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vancells Lujan, P., Vinas Esmel, E., and Sacanella Meseguer, E. (2021). Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food composition and other dietary components in its development. Nutrients, 13.","DOI":"10.3390\/nu13051442"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Silva","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction) associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2017.01.023","article-title":"Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis","volume":"111","author":"Bellanti","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4254\/wjh.v7.i10.1325","article-title":"Oxidative Stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis","volume":"7","author":"Polimeni","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochandrial dysfunction and signalling in chronic liver disease","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yang, J., Fernandez-Galilea, M., Martinez-Fernandez, L., Gonzalez-Muniesa, P., Perez-Chavez, A., Martinez, J.A., and Moreno-Aliaga, M.J. (2019). Oxidative stress and non-alcoholic fatty liver disease: Effects of omega-3 fatty acid supplementation. Nutrients, 11.","DOI":"10.3390\/nu11040872"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cicero, A.F.G., Colletti, A., and Bellentani, S. (2018). Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): Tha available clinical evidence. Nutrients, 10.","DOI":"10.3390\/nu10091153"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"110585","DOI":"10.1016\/j.fct.2019.110585","article-title":"An overview of monacolin K\/lovastatin","volume":"131","author":"Xiong","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"892697","DOI":"10.1155\/2012\/892697","article-title":"Study of the effects of monacolin K and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome","volume":"2012","author":"Fujimoto","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Parra-Vargas, M., Rodriguez-Ecchevarria, R., and Jimenez-Chillaron, J.C. (2020). Nutritional approaches for the management of nonalcoholic fatty liver disease: And evidence-based review. Nutrients, 12.","DOI":"10.3390\/nu12123860"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosissup.2017.05.021","article-title":"Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolemia patients: A clinical study","volume":"30","author":"Stefanutti","year":"2017","journal-title":"Atheroscler. Suppl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/HYPERTENSIONAHA.122.19472","article-title":"Differences in regulation of cortisol secretion contribute to left ventricular abnormalities in patients with essential hypertension","volume":"79","author":"Brosolo","year":"2022","journal-title":"Hypertension"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1159\/000484299","article-title":"Long-term renal and cardiac outcomes after stenting in patients with resistant hypertension and atherosclerotic renal artery stenosis","volume":"42","author":"Catena","year":"2017","journal-title":"Kidney Blood Press. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Brosolo, G., Da Porto, A., Bulfone, L., Scandolin, L., Vacca, A., Bertin, N., Vivarelli, C., Sechi, L.A., and Catena, C. (2022). Vitamin D deficiency is associated with glycometabolic changes in nondiabetic patients with arterial hypertension. Nutrients, 14.","DOI":"10.3390\/nu14020311"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.alc.0000183004.28587.23","article-title":"Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal","volume":"29","author":"Soardo","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1030968","DOI":"10.3389\/fcvm.2022.1030968","article-title":"Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-na\u00efve patients with uncomplicated hypertension","volume":"9","author":"Catena","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"LIDO Study Group. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuck","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of noninvasive scoring systems in patients with nonalcoholic fatty liver disease","volume":"75","author":"Younes","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1055\/s-0035-1554659","article-title":"Evaluation of acoustic radiation force impulse imaging (ARFI) for the determination of liver stiffness using transient elastography as a reference in children","volume":"1","author":"Sagir","year":"2015","journal-title":"Ultrasound Int. Open"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Da Porto, A., Tascini, C., Peghin, M., Sozio, E., Colussi, G.L., Casarsa, V., Bulfone, L., Graziano, E., De Carlo, E., and Catena, C. (2021). Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with COVID-19 pneumonia: A prospective study. Nutrients, 13.","DOI":"10.3390\/nu13114085"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","article-title":"Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study","volume":"47","author":"Ekstedt","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clnu.2016.12.009","article-title":"Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease iin children","volume":"37","author":"Chen","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.14797\/mdcj-15-3-192","article-title":"Red yeast rice for hypercholesterolemia","volume":"15","author":"Cicero","year":"2019","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2018.05.015","article-title":"Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper","volume":"134","author":"Poli","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain. A systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_35","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on thje management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Munkong, N., Lonan, P., Mueangchang, W., Yadyookai, N., Kanjoo, V., and Yoysungnoen, B. (2022). Red rice bran extract attenuates adipogenesis and inflammation on white adipose tissues in high-fat diet-induced obese mice. Foods, 11.","DOI":"10.3390\/foods11131865"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Teng, T., Qiu, S., Zhao, Y., Zhao, S., Sun, D., Hou, L., Li, Y., Zhou, K., Yu, X., and Yang, C. (2022). Pathogenesis and therapeutic strategies related to non-alcoholic fatty liver disease. Int. J. Mol. Sci., 16.","DOI":"10.3390\/ijms23147841"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/10715762.2019.1635691","article-title":"Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients","volume":"53","author":"Maciejczyk","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5152\/tjg.2016.16106","article-title":"Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease","volume":"27","author":"Canbakan","year":"2016","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/met.2010.0140","article-title":"Oxidative stress is activated by free fatty acids in cultured human hepatocytes","volume":"9","author":"Soardo","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","article-title":"Model of nonalcoholic steatohepatitis","volume":"79","author":"Lieber","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1478-3231.2008.01794.x","article-title":"Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and non-alcoholic fatty liver disease","volume":"29","author":"Hori","year":"2009","journal-title":"Liver Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1746.2007.05070.x","article-title":"Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease","volume":"23","author":"Piemonte","year":"2008","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/8\/1887\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:33Z","timestamp":1760123733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/8\/1887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["nu15081887"],"URL":"https:\/\/doi.org\/10.3390\/nu15081887","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}